EVMN ▲ +6.6% - Evommune, Inc. $EVMN - Evommune Enters into Agreement to In-License EVO570, a Potential Best-in-Class Oral VAV1 Molecular Glue Degrader, from Hinova Pharmaceuticals 04-NOV-2026 05:10 PM ET